ConocoPhillips On Pace for Record High Close -- Data Talk
Dow Jones2026/09/01 15:37ConocoPhillips (COP) is currently at $134.96, up $2.47 or 1.86%
--Would be new all-time closing high (Based on available data back to Jan. 21, 1972)
--Would be the first record close since Nov. 7, 2022, when it closed at $134.94
--On pace for largest percent increase since Aug. 20, 2026, when it rose 3.3%
--Currently up three consecutive days; up 4.2% over this period
--Best three day stretch since the three days ending Aug. 20, 2026, when it rose 5.75%
--Up 44.17% year-to-date
--Up 36.34% from 52 weeks ago (Sept. 2, 2025), when it closed at $98.99
--Would be a new 52-week closing high
--Up 57.55% from its 52-week closing low of $85.66 on Nov. 6, 2025
--Traded as high as $135.39; highest intraday level since Aug. 24, 2026, when it hit $135.63
--Up 2.19% at today's intraday high
All data as of 11:34:42 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 01, 2026 11:37 ET (15:37 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bravo Mining reports Luanga project PFS with after-tax NPV8% of US$1.45 billion
Stonepeak makes equity investment in AMPYR Distributed Energy
Novo Nordisk (NVO.US) Capital Markets Day underwhelms: CEO admits too many commitments, insufficient fulfillment, and the need to rebuild investor confidence
Novo Nordisk CEO Lars Fruergaard Jørgensen said in an interview on Tuesday that the company must make greater efforts to rebuild investor confidence, as its largest drug will face a patent cliff in the early part of the next decade.